Introduction
secondary to outcomes related to mental health (e.g. financial or physical co-164 morbidities).
165
Rationale for chosen study designs 166 Cohort studies, case-controls and cross-sectional studies that quantitatively measured 167 psychosocial outcomes such as mental illness or QoL using a validated tool in this 168 population were included. Systematic reviews (including and in addition to the review 169 by Bennis et al 2018) were also included as a mechanism for identifying relevant 170 publication for screening.
172
Study eligibility criteria 173 The inclusion and exclusion criteria used to select studies is shown in the protocol (32), 174 which used an adapted PICOS framework for observational studies. As this study was 175 examining observational studies and not randomised control studies, there was no
176
"intervention" being studied, and instead, the term "exposure" was used. There was also 177 no comparator in observational studies, so this domain was not used.
179
Rationale for chosen population 180 Due to the broad exploratory nature of this systematic review, all patients with any form 181 of leishmaniasis regardless of age and gender were included. We also included 182 assessments of how the disease has wider impacts on family and community members 183 due, for example, to social stigma and financial strain (35, 36) .
Rationale for chosen exposures

186
The exposures included the social determinants of health associated with leishmaniasis 187 including: poverty, low social economic status, co-morbid infections, social and cultural 188 norms, as well as the physical and psychosocial factors that could lead to a decrease in 189 QoL, PM and MI. 190 191 Data extraction 192 Titles and abstracts were downloaded onto EndNote and de-duplicated. These were then 193 transferred onto an excel spreadsheet and screened independently by two reviewers (MP 194 and VM). Any disagreement between these two authors were resolved by a third 195 reviewer (RC). Screening codes for titles and abstracts were also created. After selecting 
Quality Assessment and Risk of Bias
211
The tool to assess quality and risk of bias for the cohort and case-control studies was the 212 Newcastle-Ottawa Scale (NOS) (37) as suggested in the Cochrane Handbook (38). For 213 cross-sectional studies, an adapted version of the NOS was used (39). For any SRs 214 identified during the selection process, the ROBIS tool for assessing the risk of bias was 215 used. The tool is comprised of three phases: 1) assess relevance, 2) identify concerns 216 with the review process, and 3) judge risk of bias (40).
218
Methodological Quality Appraisal of Studies
219
The methodological quality of the studies was assessed for the 13 primary studies using 220 the NOS risk of bias tool, as described above; the systematic review (Bennis et al., 221 2018)was assessed using ROBIS. An adapted version of NOS was used to appraise the 222 quality of the cross-sectional studies (39). The case-control studies and cohort study 223 were appraised using the original version of NOS.
Study Characteristics
235
236
A total of 14 publications (consisting of 13 full articles and 1 conference proceeding) 237 met all of the inclusion criteria for this systematic review (41, 42, (51) (52) (53) (54) (43) (44) (45) (46) (47) (48) (49) (50) (42, 43, 46) ; 10 studied CL (41, 44, 45, 48, 49, (51) (52) (53) (54) (55) and one PKDL (50) ( Table 1 ). All 241 studies were performed in LMICs (Table 1) . 
Study Design
263
Nine studies were cross-sectional (42, (44) (45) (46) 48, 49, 51, 53, 55) , three were case-control ( 264 Pal et al., 2017; Turan et al., 2015; Yanik et al., 2004) , one was a prospective cohort 265 study (43) and one a systematic review (41). The characteristics of the 14 included 266 studied that met the eligibility criteria were assessed for quantitative synthesis.
267
Diagnostic Criteria
270
The different instruments to measure the outcomes for each of the 14 publications are 271 shown in Table 1 . showing poor quality of life. Importantly depression was strongly and consistently 281 associated with all the QoL domains in HIV-VL patients (as it was in the HIV group.
282
The mean (SD) depressive-symptoms scale scores were higher 2.67 (±0.7) for HIV-VL patients were significantly lower compared to the HIV group (p=0.001).
288
Another study looked at knowledge attitudes and practices (KAP) about VL among 289 adults in a community in India. It was found that 7.6% of the participants agreed with 290 the statement that the incidence of VL in the family should not be disclosed. to the need for loans (17.6%), forced to sell property (0.7%) and other (15.5%) (46).
Cutaneous leishmaniasis
297
The cross-sectional study by Chahed et al, 2016, given that inflammation associated with other diseases has been shown to be associated to demonstrate a high burden of co-morbid depression in both active and inactive forms of the disease (70) .
539
The only studies including a co-morbidity were part of the same study assessed at 540 baseline (cross-sectional) (42) (prospective cohort) (43) the suffering is long-term with the consequences of the disease for life (50, 51, 54) .
558
We used the results of the review to develop a conceptual framework (Figure 1 and modern large cross-sectional study with VL patients to study if there is associated 588 mental illness in these patients would be an important aspect to investigate. This 589 research needs to be designed in culturally appropriate ways given the variety of low-
590
and middle-income country settings that the disease is to be found. 
Clinical and Policy Implications
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